Bright Minds Biosciences logo

Bright Minds Biosciences

DRUG | NASDAQ
Chart Builder DCF Calculator
$22.61
-$0.50 (-2.16%)
At close: Nov 16, 2026, 4:00 PM ET
$22.61
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.16%

Rating

Updated: Nov 16, 2026
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #958/1021 (Top 94%)

Key Statistics

Market Data

Market Cap $223.03M
1D Range
21.56 24.28
52W Range
18.96 95.99

Valuation (TTM)

PE -11.32
PB 1.03
EV/EBITDA -0.25

Valuation (NTM)

Forward PE N/A
Forward PEG -0.09
Price Target $147.50
Loading financial charts...

Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2...

Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Mar 22, 2021
Fiscal Year October - September

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$147.50
Upside
+552.37%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.